Latest Amgen Stories
Plans to Payout Approximately 60 Percent of Adjusted Net Income on Average to Shareholders Through 2018 NEW YORK, Oct.
THOUSAND OAKS, Calif., Oct. 23, 2014 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that it will hold its Business Review Meeting on Tuesday, Oct.
THOUSAND OAKS, Calif., Oct.
RnRMarketResearch.com adds “Osteoporosis & Osteoarthritis – Pipeline Review, H2 2014” to its store.
A California man filed a class action lawsuit against Immunex and Caremark CVS alleging that the pharmacy fails to properly refrigerate best-selling drug Enbrel when filling a mail order Caremark
THOUSAND OAKS, Calif., Oct. 17, 2014 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced the appointment of R.
THOUSAND OAKS, Calif., Oct. 17, 2014 /PRNewswire/ -- Amgen (NASDAQ: AMGN) announced that its Board of Directors today declared a $0.61 per share dividend for the fourth quarter of 2014.
Amgen Seeks Injunction Related to PCSK9 Inhibitor THOUSAND OAKS, Calif., Oct.
Additional Global Regulatory Filings Reinforce Commitment to Addressing Significant Unmet Needs for Patients With This Aggressive Cancer With Limited Treatment Options THOUSAND OAKS,
- To befool; deceive; balk; jilt.
- An illusion; a trick; a cheat.